Combination therapy for depression

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/137 (2006.01) A61K 31/505 (2006.01) A61P 25/24 (2006.01)

Patent

CA 2691208

A combination therapy for treating depressive disorders is provided herein. The combination therapy comprises administering an effective amount of bupropion or its metabolites together with at least one serotonin 5-HTIA partial agonist or its metabolites to a patient in need of treatment of the depressive disorder. Pharmaceutical formulations, including packaged pharmaceutical formulations, comprising this combination are also provided herein.

L'invention porte sur une thérapie par combinaison pour traiter des troubles dépressifs. La thérapie par combinaison comprend l'administration d'une quantité efficace de bupropion ou de ses métabolites conjointement avec au moins un agoniste partiel de la sérotonine 5-HTIA ou de ses métabolites à un patient ayant besoin d'un traitement du trouble dépressif. L'invention porte également sur des formulations pharmaceutiques, y compris des formulations pharmaceutiques conditionnées, comprenant cette combinaison.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination therapy for depression does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination therapy for depression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy for depression will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1850785

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.